Researchers at Auburn University, in collaboration with scientists from the University of Basel and ETH Zurich, have made an advance in the fight against cancer. The team, led by Dr. Rafael Bernardi, Associate Professor of Biophysics in the Department of Physics, has developed a novel approach integrating artificial intelligence (AI) with molecular dynamics simulations and network analysis to enhance the prediction of binding sites on the PD-L1 protein. This breakthrough promises to accelerate the development of personalized cancer treatments by identifying critical interaction points in cancer-related proteins.
